Clinical Trials Directory

Trials / Completed

CompletedNCT04941066

Cognitive Process-based Real-time fMRI Neurofeedback in MDD and Rumination

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Laureate Institute for Brain Research, Inc. · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the feasibility and efficacy of real-time fMRI neurofeedback for rumination.

Detailed description

Neuroimaging MRI techniques for measuring brain structure, tissue composition, and Blood Oxygenation Level Dependent functional Magnetic Resonance imaging (BOLD fMRI) will be used to measure task-dependent and task-independent brain hemodynamic and electrophysiological changes in human subjects with major depressive disorders (MDD). After being informed about the study and potential risks, all participants giving written informed consent will undergo one session of the cognitive process-based fMRI neurofeedback (CNF) targeting the rumination-related brain functional connectivity, and a one-week follow-up. Participants will be randomized in a double-blind manner (participant and investigator) in a 1:1 ratio to Active (receiving feedback from their own brain activity) or Sham (receiving artificially generated feedback).

Conditions

Interventions

TypeNameDescription
BEHAVIORALActive neurofeedbackThe session will be done on an individual basis. The active group will receive neurofeedback training from the rumination-related brain functional connectivity.
BEHAVIORALSham neurofeedbackThe session will be done on an individual basis. The sham group will receive neurofeedback training from an artificially generated random feedback signal.

Timeline

Start date
2021-03-01
Primary completion
2022-03-31
Completion
2022-03-31
First posted
2021-06-28
Last updated
2023-01-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04941066. Inclusion in this directory is not an endorsement.